# AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer

> **NCT06788366** · — · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 2000 (estimated)

## Conditions studied

- NSCLC Stage IV

## Interventions

- **DRUG:** Immunotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06788366
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788366, "AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06788366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*